AMY SPINELLA: Open Payments
NPI 1386167047 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,477 in 68 payments from 16 companies in 2025. Trend: 2023 $1,455 · 2024 $1,710 · 2025 $1,477
Food & beverage: $1,477
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $403 |
| ABBVIE INC. | 17 | $271 |
| Sumitomo Pharma America, Inc. | 13 | $251 |
| PFIZER INC. | 3 | $105 |
| UROGEN PHARMA, INC. | 5 | $85 |
| Endo USA, Inc. | 4 | $81 |
| Ferring Pharmaceuticals Inc. | 3 | $51 |
| 180 Medical, Inc. | 2 | $47 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| IMMUNITYBIO, INC. | 1 | $34 |
Products named: ERLEADA, BOTOX, GEMTESA, TALZENNA, ADSTILADRIN, GENTLECATH GLIDE, ORGOVYX, XIAFLEX.
Industry payments across AL — which companies pay providers there.
